Verifying…
Home / Drug A–Z / Augmentin Tablets 375 mg

Augmentin Tablets 375 mg

NAFDAC Reg. No. 04-2466 · Drug

Registered with NAFDAC — registration activeAs of 5 November 2026 · synced automatically from official sources.
Product
Augmentin Tablets 375 mg
NAFDAC number
04-2466
Active ingredient
Amoxicillin (Amoxicillin Trihydrate); Clavulanic Acid (Potassium Clavulanate)
Strength
250 mg; 125 mg
Form
Tablet
Pack size
2 x 10's (in blisters)
Manufacturer
Not listed
Applicant (holder)
GlaxoSmithKline Consumer Nigeria PLC (GSK)
Approved
26 Apr 2023
Status
Active View on NAFDAC ↗
Registration valid to
25 Apr 2028
WHO alerts
None found
Community reports
None
Times checked
0

RxVerify commentary

  • Augmentin Tablets 375 mg is on the NAFDAC register with an active registration (04-2466). A valid number alone does not prove a pack is genuine — counterfeiters copy real numbers, so also check the expiry date, seal and print quality.

Generated automatically from the NAFDAC register, WHO alerts and community data as of today. Not medical advice — always follow your doctor or pharmacist.

What Augmentin Tablets 375 mg is used for

From the official U.S. FDA label for amoxicillin (amoxicillin trihydrate), the active ingredient registered with NAFDAC.

What it is used for

Adults and Pediatric Patients Upper Respiratory Tract Infections of the Ear, Nose, and Throat: Amoxicillin tablets are indicated in the treatment of infections due to susceptible (ONLY β-lactamase-negative) isolates of Streptococcus species. (α- and β-hemolytic isolates only), Streptococcus pneumoniae , Staphylococcus spp., or Haemophilus influenzae . Infections of the Genitourinary Tract: Amoxicillin tablets are indicated in the treatment of infections due to susceptible (ONLY β-lactamase–negative) isolates of Escherichia coli, Proteus mirabilis , or Enterococcus faecalis . …

Possible side effects

The following are discussed in more detail in other sections of the labeling: Anaphylactic reactions [see Warnings and Precautions (5.1) ] Severe Cutaneous Adverse Reactions [see Warnings and Precautions (5.2) ] Clostridioides difficile- Associated Diarrhea (CDAD) [see Warnings and Precautions (5.3) ] The most common adverse reactions (greater than 1%) observed in clinical trials of amoxicillin tablets or for oral suspension were diarrhea, rash, vomiting, and nausea. (6.1) To report SUSPECTED ADVERSE REACTIONS, contact Aurobindo Pharma USA, Inc. at 1-866-850-2876 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch . …

Do not use if

Amoxicillin tablets are contraindicated in patients who have experienced a serious hypersensitivity reaction (e.g., anaphylaxis or Stevens-Johnson syndrome) to amoxicillin tablets or to other β-lactam antibacterial drugs (e.g., penicillins and cephalosporins). History of a serious hypersensitivity reaction (e.g., anaphylaxis or Stevens-Johnson syndrome) to amoxicillin tablets or to other beta-lactams (e.g., penicillins or cephalosporins). (4)

Warnings

Anaphylactic reactions: Serious and occasionally fatal anaphylactic reactions have been reported in patients on penicillin therapy, including amoxicillin. Discontinue amoxicillin if a reaction occurs ( 5.1 ). Severe cutaneous adverse reactions (SCAR): Monitor closely. Discontinue if rash progresses. ( 5.2 ) Clostridioides difficile -associated diarrhea (CDAD) (ranging from mild diarrhea to fatal colitis): Evaluate if diarrhea occurs. ( 5.3 ) 5.1 Anaphylactic Reactions Serious and occasionally fatal hypersensitivity (anaphylactic) reactions have been reported in patients on penicillin therapy including amoxicillin. …

Pregnancy & breastfeeding

8.1 Pregnancy Teratogenic Effects : Pregnancy Category B. Reproduction studies have been performed in mice and rats at doses up to 2000 mg/kg (3 and 6 times the 3 g human dose, based on body surface area). There was no evidence of harm to the fetus due to amoxicillin. There are, however, no adequate and well-controlled studies in pregnant women. …

General information only — not dosing advice. Always follow the leaflet in your pack and your doctor or pharmacist.

NAFDAC recall & alert notices

Public Alert No. 024/2026 – Alert on Counterfeit Augmentin 625mg Tablets (Batch No. AC3N) in Nigeria30 Apr 2026 · nafdac.gov.ngThe National Agency for Food and Drug Administration and Control (NAFDAC) is notifying healthcare providers and the public of the circulation of counterfeit or falsified Augmentin 625mg Tablets (2 x 7 tablets pack) with Batch No. AC3N in Nigeria.NAFDAC has received information from the Marketing Authorization Holder fo…Public Alert No: 42 – NAFDAC Alert And Sensitization Of The Public On Suspected Falsified Augmentin 625mg22 Oct 2022 · nafdac.gov.ng, The Agency wishes to draw the attention of the public to the detection of suspected falsified Augmentin 625mg Tablets in circulation within the country with the following details and labelling lapses; The details of the suspected falsified Augmentin 625mg Tabs are as follows; Product Name: Augmentin 625mg. Batch No.:…Public Alert No: 0016/2019 – Alert on Falsified Augmentin Products Circulating in Uganda and Kenya5 Sep 2019 · nafdac.gov.ng, The National Agency for Food and Drug Administration and Control (NAFDAC) has been notified by the World Health Organisation (WHO) on the circulation of confirmed falsified Augmentin (Amoxicillin trihydrate + Potassium clavulanate) in Uganda and Kenya. In April 2018, NAFDAC  received a similar alert from WHO on falsi…Public Alert No: 07/2018 Falsified Augmentin Products Circulating In Cameroun12 Apr 2018 · nafdac.gov.ngThe National Agency for Food and Drug Administration and Control (NAFDAC) has been notified of the circulation of a falsified version of Augmentin (Amoxycillin + Clavulanate potassium) in Cameroun. Amoxycillin + Clavulanic acid is used to treat a range of bacterial infections and is listed as a WHO Essential Medicine. …

Notices list affected brands and batch numbers — compare them with your pack. Enter your batch number above to check it automatically.

Check your pack of Augmentin Tablets 375 mg

Add the expiry date printed on your pack for a full Trust Score — or look up uses, side effects and cheaper generics.

3 free checks left today · no signup Official sources: NAFDAC Green Book & recalls · WHO · U.S. FDA · NLM RxNorm

About Augmentin Tablets 375 mg

What is in Augmentin Tablets 375 mg?

Augmentin Tablets 375 mg contains Amoxicillin (Amoxicillin Trihydrate); Clavulanic Acid (Potassium Clavulanate) (250 mg; 125 mg), as tablet, according to its NAFDAC registration record.

Is Augmentin Tablets 375 mg registered with NAFDAC?

Yes. Augmentin Tablets 375 mg is listed on the NAFDAC register under registration number 04-2466, and its registration is active as of 5 November 2026.

Has Augmentin Tablets 375 mg been flagged as fake or recalled?

No WHO falsified or substandard medical product alert currently matches Augmentin Tablets 375 mg in our automatically synced alert list.

How can I check that my pack of Augmentin Tablets 375 mg is genuine?

Run a free authenticity scan with the NAFDAC number 04-2466, your pack's expiry date and batch number to get a Trust Score, compare the pack with the NAFDAC record (ingredient, strength, form, manufacturer), and buy only from licensed pharmacies.

What is Augmentin Tablets 375 mg used for?

Adults and Pediatric Patients Upper Respiratory Tract Infections of the Ear, Nose, and Throat: Amoxicillin tablets are indicated in the treatment of infections due to susceptible (ONLY β-lactamase-negative) isolates of Streptococcus species. (α- and β-hemolytic isolates only), Streptococcus pneumoniae , Staphylococcus spp., or Haemophilus influenzae . Infections of the Genitourinary Tract: Amoxici (Summarised from the official U.S. FDA label for amoxicillin (amoxicillin trihydrate). Always follow your doctor or pharmacist.)

Patient reviews

–No reviews yet
5★
0
4★
0
3★
0
2★
0
1★
0
Have you used Augmentin Tablets 375 mg? Share your experience to help other patients. Sign in to review

Reviews are personal experiences from RxVerify users, not medical advice. Report side effects to your doctor and to NAFDAC.